PL368231A1 - Zastosowanie inhibitorów IL-18 w zaburzeniach związanych z nadwrażliwością - Google Patents

Zastosowanie inhibitorów IL-18 w zaburzeniach związanych z nadwrażliwością

Info

Publication number
PL368231A1
PL368231A1 PL02368231A PL36823102A PL368231A1 PL 368231 A1 PL368231 A1 PL 368231A1 PL 02368231 A PL02368231 A PL 02368231A PL 36823102 A PL36823102 A PL 36823102A PL 368231 A1 PL368231 A1 PL 368231A1
Authority
PL
Poland
Prior art keywords
inhibitors
hypersensitivity disorders
hypersensitivity
disorders
Prior art date
Application number
PL02368231A
Other languages
English (en)
Other versions
PL227130B1 (pl
Inventor
Yolande Chvatchko
Marie Kosco-Vilbois
Original Assignee
Applied Research Systems Ars Holding N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems Ars Holding N.V. filed Critical Applied Research Systems Ars Holding N.V.
Publication of PL368231A1 publication Critical patent/PL368231A1/pl
Publication of PL227130B1 publication Critical patent/PL227130B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL368231A 2001-08-10 2002-08-01 Zastosowanie inhibitora IL -18 dowytwarzania leku PL227130B1 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP01118811 2001-08-10
EP01118811.7 2001-08-10
EP02100735.6 2002-06-20
EP02100735 2002-06-20
PCT/EP2002/008591 WO2003013577A2 (en) 2001-08-10 2002-08-01 Use of il-18 inhibitors in hypersensitivity disorders

Publications (2)

Publication Number Publication Date
PL368231A1 true PL368231A1 (pl) 2005-03-21
PL227130B1 PL227130B1 (pl) 2017-10-31

Family

ID=26076673

Family Applications (1)

Application Number Title Priority Date Filing Date
PL368231A PL227130B1 (pl) 2001-08-10 2002-08-01 Zastosowanie inhibitora IL -18 dowytwarzania leku

Country Status (26)

Country Link
US (1) US20040247598A1 (pl)
EP (1) EP1423138B1 (pl)
JP (1) JP4301942B2 (pl)
KR (1) KR20040030948A (pl)
CN (1) CN100500210C (pl)
AR (1) AR035274A1 (pl)
AU (1) AU2002331376B2 (pl)
BR (1) BRPI0211827B8 (pl)
CA (1) CA2456247C (pl)
CY (1) CY1116137T1 (pl)
DK (1) DK1423138T3 (pl)
EA (1) EA006745B1 (pl)
ES (1) ES2533253T3 (pl)
HR (1) HRP20040071B1 (pl)
HU (1) HU230377B1 (pl)
IL (2) IL160230A0 (pl)
ME (1) ME00547B (pl)
MX (1) MXPA04001230A (pl)
NO (1) NO335688B1 (pl)
PL (1) PL227130B1 (pl)
PT (1) PT1423138E (pl)
RS (1) RS52224B (pl)
SI (1) SI1423138T1 (pl)
UA (1) UA78516C2 (pl)
WO (1) WO2003013577A2 (pl)
ZA (1) ZA200400442B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5069000B2 (ja) * 2004-06-30 2012-11-07 敦生 関山 非炎症性ストレス応答の指標剤およびその利用
CA2609060C (en) 2005-06-03 2014-07-15 Urs Weber Production of recombinant il-18 binding protein
PT1891088E (pt) 2005-06-10 2011-12-19 Ares Trading Sa Processo para a purificação da proteína de ligação il-18
MX2008014842A (es) 2006-05-25 2009-02-17 Glaxo Group Ltd Anticuerpos humanizados contra interleuquina-18 modificados.
WO2012081650A1 (ja) * 2010-12-16 2012-06-21 株式会社明治 遅延型過敏症軽減剤
JP2026525821A (ja) * 2023-06-20 2026-08-04 アポロ・エイピー４３・リミテッド アトピー性皮膚炎を処置するための抗ｉｌ－１８抗体療法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US6087116A (en) * 1997-03-12 2000-07-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18 (IL-18) receptor polypeptides and their uses
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
JP4499917B2 (ja) * 1998-03-09 2010-07-14 バーテックス ファーマシューティカルズ インコーポレイテッド インターロイキン−１β変換酵素のインヒビターとしての１，２−ジアゼパン誘導体
CA2276216A1 (en) * 1998-06-24 1999-12-24 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo An artificial peptide capable of neutralizing the biological activity of interleukin-18
CA2340579A1 (en) * 1998-09-01 2000-03-09 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin 18-binding protein
WO2000071719A1 (en) * 1999-05-20 2000-11-30 Hyseq, Inc. Interleukin-1 hy2 materials and methods
WO2002032374A2 (en) * 2000-10-18 2002-04-25 Immunex Corporation Methods for treating il-18 mediated disorders

Also Published As

Publication number Publication date
IL160230A (en) 2014-11-30
ME00547B (me) 2011-12-20
PT1423138E (pt) 2015-02-09
NO20040370L (no) 2004-03-23
YU11904A (sh) 2006-08-17
CN1568193A (zh) 2005-01-19
HRP20040071A2 (en) 2004-10-31
EA006745B1 (ru) 2006-04-28
HRP20040071B1 (hr) 2015-08-28
UA78516C2 (en) 2007-04-10
HUP0401323A2 (hu) 2004-10-28
PL227130B1 (pl) 2017-10-31
HK1069780A1 (zh) 2005-06-03
ZA200400442B (en) 2005-03-30
DK1423138T3 (en) 2015-02-23
NO335688B1 (no) 2015-01-19
KR20040030948A (ko) 2004-04-09
CN100500210C (zh) 2009-06-17
MXPA04001230A (es) 2004-05-27
AU2002331376B2 (en) 2007-06-14
BR0211827A (pt) 2004-08-31
EP1423138A2 (en) 2004-06-02
JP4301942B2 (ja) 2009-07-22
AR035274A1 (es) 2004-05-05
SI1423138T1 (sl) 2015-04-30
US20040247598A1 (en) 2004-12-09
WO2003013577A2 (en) 2003-02-20
RS52224B (sr) 2012-10-31
WO2003013577A3 (en) 2003-09-25
BRPI0211827B8 (pt) 2021-05-25
EA200400296A1 (ru) 2004-06-24
HUP0401323A3 (en) 2006-01-30
IL160230A0 (en) 2004-07-25
CA2456247C (en) 2013-09-10
CA2456247A1 (en) 2003-02-20
JP2005501080A (ja) 2005-01-13
BRPI0211827B1 (pt) 2019-07-23
EP1423138B1 (en) 2014-12-24
HU230377B1 (hu) 2016-03-29
CY1116137T1 (el) 2017-02-08
ES2533253T3 (es) 2015-04-08

Similar Documents

Publication Publication Date Title
AU2003259735A8 (en) Small-mer compositions and methods of use
IL210091A0 (en) TREATMENT OF TNFa RELATED DISORDERS
AU2003303128A8 (en) Inhibitors and methods of use thereof
IL166780A0 (en) Use of ikappab-kinase inhibitors in pain therapy
HUP0401023A3 (en) Use of flibanserin in the treatment of sexual disorders
AU2002352483A1 (en) Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
PL374598A1 (pl) Inhibitory kaspazy i ich zastosowania
IL164211A0 (en) Il-18 inhibitors and peripheral vascular diseases
EP1383743A4 (en) DOUBLE INHIBITORS OF PDE 7 AND PDE 4
EP1549614A4 (en) VASCULATORY AGENTS AND METHODS FOR THEIR APPLICATION
HUP0300061A3 (en) Use of il-18 inhibitors
ZA200509700B (en) Caspase inhibitors and uses thereof
ZA200410409B (en) Use of thio-oxindole derivatives in treatment of hormonerelated conditions
AU2003287443A8 (en) Compositions and methods for pain reduction
AU2003299441A8 (en) Nf-hev compositions and methods of use
AU2003210983A8 (en) Kinase inhibitors and methods of use thereof
PL368321A1 (pl) Zastosowanie cystationiny
IL131047A0 (en) Use of il-18 inhibitors
IL157024A0 (en) Il-18 inhibitors in heart disease
GB0615918D0 (en) Composition and its therapeutic use
HUP0401323A3 (en) Use of il-18 inhibitors in hypersensitivity disorders
AU2003206945A8 (en) Use of proteinase inhibitors in the treatment of autoimmune diseases
PL363544A1 (pl) Nowe pochodne piperazynowe
AU2003251513A8 (en) Rsk inhibitors and therapeutic uses thereof
EP1534293A4 (en) INFLAMMATORY COMPOSITIONS AND METHODS OF ADMINISTRATION